Bright Path Labs  chosen as a collaborator in a first-ever National Science Foundation Engines Award

Bright Path is proud to have been chosen to collaborate with the The Puerto Rico  Science, Technology, & Research Trust in a $1M NSF Innovation Engines Development Award

Mar 24, 2020

Bright Path Laboratories, Inc. (privately held) 3-year-old startup contract manufacturer – with offices in both Charlotte and Santa Fe, N.M. – recently got a strong show of support from The U.S. Food and Drug Administration for its patented spinning-tube-in-tube (STT) continuous-flow reactor.

The agency accepted the system, the only one of its kind that manufactures active pharmaceutical ingredients (APIs), into the FDA’s Emerging Technology Program. That program promotes innovative approaches to pharmaceutical product design and manufacturing.

For the full article from the North Carolina, Biotech Center see www.ncbiotech.org/news/bright-path-laboratories-develops-new-way-produce-active-pharmaceutical-ingredients.